Check out our most popular compounded medications! Get Started
Chlorpheniramine Maleate 8 mg/Pseudoephedrine HCl 60 mg/Guaifenesin 200 mg/Dextromethorphan HBr 30 mg Slow Release Capsules is a compounded formulation designed to gradually release the active ingredients over an extended period. This formulation, which uses Methocel E4M, a controlled-release polymer, offers sustained therapeutic effects and improved patient compliance due to reduced dosing frequency. It is used to treat conditions such as Allergic Rhinitis, Common Cold, Cough, Nasal Congestion, and Sinusitis.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy's Chlorpheniramine Maleate 8 mg/Pseudoephedrine HCl 60 mg/Guaifenesin 200 mg/Dextromethorphan HBr 30 mg Slow Release Capsules are a meticulously compounded formulation designed to alleviate a wide range of symptoms associated with allergies, colds, and flu. This unique formulation is encapsulated with Methocel E4M, a controlled-release polymer, which ensures the gradual release of the active ingredients over an extended period of time.
This slow-release mechanism offers sustained therapeutic effects, reducing the need for frequent dosing and enhancing patient compliance, particularly for medications requiring a controlled and prolonged release profile. The formulation is designed to provide long-lasting relief from symptoms such as nasal congestion, sneezing, runny nose, itchy eyes, coughing, and chest congestion.
It is crucial to adhere to the directions on the package and to take the medication as prescribed by your healthcare provider.
If you have any questions about this formulation or how it can help manage your symptoms, please do not hesitate to contact us at Bayview Pharmacy. We are committed to providing you with the highest quality of care and service.
Chlorpheniramine Maleate 8 mg/Pseudoephedrine HCl 60 mg/Guaifenesin 200 mg/Dextromethorphan HBr 30 mg Slow Release Capsules are designed to provide relief from symptoms associated with upper respiratory allergies and the common cold. These symptoms may include sneezing, runny nose, itchy and watery eyes, nasal congestion, cough, and sore throat. The formulation may also be used to treat other conditions as determined by your healthcare provider.
The capsules are formulated with Methocel E4M, a type of controlled-release polymer. This design allows for the gradual release of the encapsulated medication or active ingredient over an extended period of time. This offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
It's important to note that this formulation may interact with other medications, including but not limited to, monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, and other antihistamines. Patients should inform their healthcare provider of all medications they are taking, including over-the-counter medications, vitamins, and herbal supplements. Additionally, patients should inform their healthcare provider of any medical conditions they have, such as glaucoma, hypertension, heart disease, or thyroid disease.
Patients should not take this formulation if they are allergic to any of the ingredients, or if they are pregnant or breastfeeding. It's also advised not to take this formulation if they are taking any other medications that contain pseudoephedrine, guaifenesin, or dextromethorphan.
Caution is advised when taking this formulation, as it may cause drowsiness or dizziness. Patients should not drive or operate heavy machinery until they know how this formulation affects them. It's also recommended to avoid alcohol while taking this formulation.
If you have any questions about this formulation, please consult with your healthcare provider.
This compounded formulation of Chlorpheniramine Maleate 8 mg, Pseudoephedrine HCl 60 mg, Guaifenesin 200 mg, and Dextromethorphan HBr 30 mg in slow-release capsules is a comprehensive treatment for a range of conditions such as allergies, colds, and coughs. Each component of this formulation plays a crucial role in symptom relief. Chlorpheniramine Maleate, an antihistamine, blocks the action of histamine, a substance in the body that triggers allergic symptoms. Pseudoephedrine HCl, a decongestant, narrows the blood vessels in the nasal passages, thereby reducing congestion. Guaifenesin, an expectorant, aids in thinning and loosening mucus in the lungs, making it easier to cough up. Lastly, Dextromethorphan HBr, a cough suppressant, works by decreasing the activity of the cough reflex in the brain.
What sets this formulation apart is its slow-release feature, achieved through the use of Methocel E4M, a controlled-release polymer. This design ensures a gradual release of the encapsulated medication over an extended period, offering sustained therapeutic effects. This slow-release mechanism allows for a more consistent level of the medication in the body. This also means reduced dosing frequency, which can lead to improved patient compliance, especially for medications requiring a controlled and prolonged release profile.
If you have any questions about this formulation or its mechanism of action, please do not hesitate to reach out. We are here to assist you.
This compounded formulation consists of Chlorpheniramine Maleate 8 mg, Pseudoephedrine HCl 60 mg, Guaifenesin 200 mg, and Dextromethorphan HBr 30 mg in slow-release capsules.
Methocel E4M is a type of controlled-release polymer. It is designed to release the encapsulated medication or active ingredient gradually over an extended period of time. This offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
Slow-release capsules offer several benefits. They provide sustained therapeutic effects, reduce the frequency of dosing, and improve patient compliance, especially for medications that require a controlled and prolonged release profile.
Chlorpheniramine Maleate is an antihistamine used to relieve symptoms of allergy, hay fever, and the common cold. These symptoms include rash, itching, watery eyes, itchy eyes/nose/throat, cough, runny nose, and sneezing.
Pseudoephedrine HCl is a decongestant that shrinks blood vessels in the nasal passages. It is used to treat nasal and sinus congestion, or congestion of the tubes that drain fluid from your inner ears.
Guaifenesin is an expectorant. It helps loosen congestion in your chest and throat, making it easier to cough out through your mouth.
Dextromethorphan HBr is a cough suppressant. It affects the signals in the brain that trigger cough reflex.
The frequency of dosing will depend on your specific condition and the advice of your healthcare provider. However, due to the slow-release nature of these capsules, the frequency of dosing may be less than with traditional formulations.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Take your next dose at the regular time. Do not double the dose to catch up.
Like all medications, this formulation can cause side effects. Common side effects may include dizziness, drowsiness, dry mouth/nose/throat, headache, upset stomach, constipation, or trouble sleeping. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
